Abstract:The serum uric acid to serum creatinine ratio (SUA/sCr) is a standardized index of renal function. More importance was attached to the significance of this ratio in the progression of hypertension. While the association between the prognosis of hypertension and SUA/sCr is unknown. Therefore, we aimed to prospectively examine the associations of serum uric acid to serum creatinine ratio and all-cause and CVD mortality in adults with hypertension. Participants with hypertension from NHANES 1999-2018 (n = 15,269) were included. They were stratified by 1 increment of SUA/sCr ratio and categorized into 6 groups as ≤ 4, > 4 to 5, > 5 to 6, > 6 to 7, > 7 to 8, and > 8. The reason for categorization in 6 groups was to analyze the influence of different ratios on outcomes accurately and provide more precise guidance. The sample size is large enough that even if divided into 6 groups, it does not affect the statistical power. The primary outcomes were all-cause and CVD mortality. Weighted multivariable Cox proportional hazards regression models were used to estimate hazard ratio (HRs) of mortality. Restricted cubic spline regression models were utilized to examine dose-response associations between the serum uric acid to serum creatinine ratio and all-cause and CVD mortality. Relatively comprehensive stratified analyses were conducted to confirm the accuracy and stability of the results. There were 15,269 total participants, 49.4% of whom were men, with an average age of 56.6 years. Weighted multivariable Cox proportional hazards regression models demonstrated participants in the lowest group (≤ 4) had the HRs (95% CIs) of 1.43 (1.18, 1.73) for all-cause mortality and 2.8 (1.92, 4.10) for CVD mortality when compared to the reference group. Participants in the highest group (> 8) had the HRs (95% CIs) of 0.47 (0.25, 0.89) for CVD mortality when compared to the reference group. There were progressively lower risks for all-cause and CVD mortality with the SUA/sCr ratio increased (both P trend < 0.01). The SUA/sCr ratio was (P for nonlinearity < 0.01) nonlinearly correlated with all-cause mortality, with inflection points of 6.25. In addition, the restricted cubic splines results indicated that the SUA/sCr ratio (P for nonlinearity = 0.32) showed linear and negative associations with cardiovascular mortality with inflection points of 6.54. The inverse associations between SUA/sCr ratio and all-cause mortality were consistent across all subgroups except for the subgroup of eGFR < 45 ml/min/1.73 m2 and never smokers (P trend = 0.20 and 0.13, respectively), and the inverse associations between low SUA/sCr ratio and CVD mortality were consistent across all subgroups (P trend < 0.01). Contrary to previous studies, outcomes suggest that lower SUA/sCr ratio was associated with higher risks of all-cause and CVD mortality in adults with hypertension.

The association of low serum uric acid with mortality in older people is modified by kidney function: National Health and Nutrition Examination Survey (NHANES) 1999–2018

Association Between Serum Uric Acid Levels and Long-Term Mortality of Metabolic Dysfunction-Associated Fatty Liver Disease: a Nationwide Cohort Study

Associations of Serum Uric Acid Levels with Liver Disease-Related Morbidity and Mortality: A Prospective Cohort Study of the UK Biobank.

The association between time-mean serum uric acid levels and the incidence of chronic kidney disease in the general population: a retrospective study

Serum Uric Acid and Risk of Incident Chronic Kidney Disease: a National Cohort Study and Updated Meta-Analysis.

Association between serum uric acid level and mortality in China

Association Between Baseline and Changes in Serum Uric Acid and Incident Metabolic Syndrome: a Nation-Wide Cohort Study and Updated Meta-Analysis.

Association between mortality and serum uric acid levels in non-diabetes-related chronic kidney disease: An analysis of the National Health and Nutrition Examination Survey, USA, 1999–2010

Association of serum uric acid to all-cause and cardiovascular mortality in patients with cardiovascular disease

Distinct Prognostic Role of Serum Uric Acid Levels for Predicting All-Cause Mortality among Chinese Adults Aged 45~75 Years with and Without Diabetes

Association of serum uric acid with all-cause and cardiovascular mortality in cardiovascular disease patients

Association between serum uric acid to serum creatinine ratio with cardiovascular and all-cause mortality in adults with hypertension

J-shaped association of serum uric acid with all-cause and cardiovascular mortality in patients with diabetic kidney disease

Association of Serum Uric Acid with All-Cause and Cardiovascular Mortality in Diabetes

U-shaped association of serum uric acid with all-cause mortality in patients with hyperlipidemia in the United States: a cohort study

Serum uric acid as a predictor of mortality in patients with stroke: results from National Health and Nutrition Examination Survey 2007–2016

Serum Uric Acid and Mortality Risk Among Hemodialysis Patients

Serum Uric Acid is Independently Associated with Aortic Arch Calcification in a Cross-Sectional Study of Middle-Aged and Elderly Women

Association Between Serum Uric Acid and the Early Marker of Kidney Function Decline among Chinese Middle-Aged and Older Population: Evidence from the China Health and Retirement Longitudinal Study.

The Effects of Cardiometabolic Factors on the Association Between Serum Uric Acid and Risk of All-Cause Mortality in Adults with Congestive Heart Failure

High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study